China Universal Asset Management Company’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Buy |
|
|||||
|
2025
Q1 | $231K | Sell |
|
|||||
|
2024
Q4 | $184K | Buy |
|
|||||
|
2024
Q3 | $134K | Buy |
|
|||||
|
2024
Q2 | $156K | Sell |
|
|||||
|
2024
Q1 | $261K | Buy |
|
|||||
|
2023
Q4 | $181K | Buy |
|
|||||
|
2023
Q3 | $36.4K | Buy |
|
|||||
|
2023
Q2 | $24.1K | Sell |
|
|||||
|
2023
Q1 | $25.4K | Buy |
|
|||||
|
2022
Q4 | $18K | Buy |
|
|||||
|
2022
Q3 | $23K | Buy |
|